Literature DB >> 23538680

Vaccines and recommendations for their use in inflammatory bowel disease.

María Dolores Sánchez-Tembleque1, Carmen Corella, Jose L Pérez-Calle.   

Abstract

The patient with inflammatory bowel disease will be predisposed to numerous infections due their immune status. It is therefore important to understand the immune and serologic status at diagnosis and to put the patient into an adapted vaccination program. This program would be applied differently according to two patient groups: the immunocompromised and the non-immunocompromised. In general, the first group would avoid the use of live-virus vaccines, and in all cases, inflammatory bowel disease treatment would take precedence over vaccine risk. It is important to individualize vaccination schedules according to the type of patient, the treatment used and the disease pattern.In addition, patient with inflammatory bowel disease should be considered for the following vaccines: varicella vaccine, human papilloma virus, influenza, pneumococcal polysaccharide vaccine and hepatitis B vaccine.

Entities:  

Keywords:  Crohn’s disease; Immunocompromised; Inflammatory bowel disease; Ulcerative colitis; Vaccines

Mesh:

Substances:

Year:  2013        PMID: 23538680      PMCID: PMC3602494          DOI: 10.3748/wjg.v19.i9.1354

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.

Authors:  M C Kapetanovic; T Saxne; J-A Nilsson; P Geborek
Journal:  Rheumatology (Oxford)       Date:  2006-11-18       Impact factor: 7.580

2.  Influenza vaccinations: should they really be encouraged for IBD patients being treated with immunosuppressives?

Authors:  Susan W Fields; Peter J Baiocco; Burton I Korelitz
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

Review 3.  Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.

Authors: 
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

Review 4.  Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.

Authors:  J P Gisbert; M Chaparro; M Esteve
Journal:  Aliment Pharmacol Ther       Date:  2011-03       Impact factor: 8.171

Review 5.  The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics.

Authors:  Uma Mahadevan; Salvatore Cucchiara; Jeffrey S Hyams; Flavio Steinwurz; F Nuti; Simon P L Travis; William J Sandborn; Jean-Frederio Colombel
Journal:  Am J Gastroenterol       Date:  2010-12-14       Impact factor: 10.864

Review 6.  Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?

Authors:  Neerja Narula; Deborah L R Yamamura; John K Marshall
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

7.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22

Review 8.  Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient.

Authors:  Mini Kamboj; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2007-04-20       Impact factor: 3.254

Review 9.  Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?

Authors:  Laurent Beaugerie
Journal:  Dig Dis       Date:  2012-07-12       Impact factor: 2.404

Review 10.  A practical guide to vaccinating the inflammatory bowel disease patient.

Authors:  Sharmeel K Wasan; Stacey E Baker; Paul R Skolnik; Francis A Farraye
Journal:  Am J Gastroenterol       Date:  2010-01-26       Impact factor: 10.864

View more
  3 in total

1.  Pregnant inflammatory bowel disease patients may require counselling regarding live vaccines in newborns.

Authors:  Adith Sekaran; Marie L Borum
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

2.  Pneumococcal vaccination rates in VHA patients with inflammatory bowel disease.

Authors:  David J Case; Laurel A Copeland; Eileen M Stock; Henry R Herrera; Timothy P Pfanner
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

Review 3.  A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.

Authors:  Júlio Maria Fonseca Chebli; Pedro Duarte Gaburri; Liliana Andrade Chebli; Tarsila Campanha da Rocha Ribeiro; André Luiz Tavares Pinto; Orlando Ambrogini Júnior; Adérson Omar Mourão Cintra Damião
Journal:  Med Sci Monit       Date:  2014-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.